Related Experiment Video
Updated: Aug 22, 2025
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.3K
Curcumin in human osteosarcoma: From analogs to carriers
Ko-Hsiu Lu1, Peace Wun-Ang Lu2, Chiao-Wen Lin3
1Department of Orthopedics, Chung Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Drug Discovery Today
|November 13, 2022
Summary
Curcumin shows anticancer potential for osteosarcoma but has poor bioavailability. This review explores curcumin analogs and nanodelivery systems to enhance treatment for metastatic bone cancer.
Area of Science:
- Oncology
- Pharmacology
- Biomaterials Science
Background:
- Osteosarcoma is a primary bone cancer with poor survival rates in metastatic cases.
- Dietary curcumin possesses anticancer properties but suffers from low bioavailability.
- Developing curcumin analogs and advanced delivery systems is crucial for clinical application.
Purpose of the Study:
- To review the biological and pharmacological characteristics of curcumin and its analogs.
- To emphasize strategies for enhancing the bioactivity and bioavailability of curcumin analogs.
- To explore novel nanoformulations and 3D printed scaffolds for osteosarcoma treatment.
Main Methods:
- Critical review of existing literature on curcumin, its analogs, and delivery systems.
- Analysis of biological and pharmacological data related to curcumin's anticancer effects.
- Evaluation of nanoformulations and 3D printed scaffolds for targeted drug delivery.
Main Results:
- Curcumin analogs and nanodelivery systems show promise in overcoming bioavailability limitations.
- Multifunctional nanoformulations and 3D printed scaffolds offer targeted delivery of curcumin.
- Strategies to improve bioactivity and bioavailability are key for effective osteosarcoma therapy.
Conclusions:
- Further research into curcumin analogs and carriers is essential.
- Enhanced bioavailability and anti-osteosarcoma activity are critical for clinical success.
- Novel delivery systems hold significant potential for treating metastatic osteosarcoma.
Related Concept Videos
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K